Achievement of HbA1c targets: real-world data from international paediatric type 1 diabetes registries
The St Vincent declaration1 calls for monitoring and comparing outcomes of diabetes care against treatment goals as a tool for quality control. National diabetes registries serve this purpose.2 In the past decade, lowering HbA1c targets in children with type 1 diabetes3 was a result of the overall improved HbA1c and, simultaneously, decreased incidence of severe hypoglycaemia.4 In the meantime, advances in diabetes technology have led to increased adoption of continuous glucose monitoring and insulin pump therapy,5 facilitating treatment among young people with type 1 diabetes.
